PAUL GARDON, Corporate Strategy

Paul is a growth-oriented Senior Executive and Legal Advisor with more than 20 years of success spanning medical devices, health services and digital technologies.

Leveraging extensive experience in strategic leadership for global businesses, Paul has expert insights regarding intellectual property, capitalization and financing, compliance, M&A, governance, human resources, strategic planning and market analysis.

Throughout his executive career, Paul has held leadership positions with The Spectranetics Corporation, Davita, Covidien and Avaya. Most recently, he served as Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer of The Spectranetics Corporation until its sale to Philips in 2017. In this role, Paul was responsible for all legal matters, strategic planning and processes, mergers and acquisitions, intellectual property and compliance that enabled the company’s enterprise value to grow from $170 million to $2.2 billion in the span of five years. Prior to Spectranetics, Paul served as General Counsel for a business unit of Davita, a leading provider of kidney care services, VP of Legal Affairs for two large divisions of Covidien and Chief IP Counsel at Avaya.

Paul holds a JD from the Villanova University School of Law and a BS from Marquette University.